Mr. Glover, who is Chairman, CEO, President, and Co-founder of ZyVersa Therapeutics, has over 32+ years of business experience in biopharmaceuticals and life sciences. Mr. Glover has multifaceted experience in Fortune 100, start up and entrepreneurial environments. He has demonstrated results in start-ups, large cap, and turnarounds, with a focus on business strategy, commercial execution, product development, business transformation and corporate development. He has over 25 life sciences transactions in licensing and M&A and has raised over $300M in capital. His strategic and operational experience includes strategic planning, corporate development, operations management, product development, product marketing and sales management. Currently Mr. Glover serves on the Board of Directors of The Coulter Foundation at the University of Miami, and he is Chairman of the Board at PDS Biotechnology and Chairman of the Board at Ambrx Biopharma.